HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Metabolic engineering of Salmonella vaccine bacteria to boost human Vγ2Vδ2 T cell immunity.

Abstract
Human Vγ2Vδ2 T cells monitor isoprenoid metabolism by recognizing foreign (E)-4-hydroxy-3-methyl-but-2-enyl pyrophosphate (HMBPP), a metabolite in the 2-C-methyl-D-erythritol-4-phosphate pathway used by most eubacteria and apicomplexan parasites, and self isopentenyl pyrophosphate, a metabolite in the mevalonate pathway used by humans. Whereas microbial infections elicit prolonged expansion of memory Vγ2Vδ2 T cells, immunization with prenyl pyrophosphates or aminobisphosphonates elicit short-term Vγ2Vδ2 expansion with rapid anergy and deletion upon subsequent immunizations. We hypothesized that a live, attenuated bacterial vaccine that overproduces HMBPP would elicit long-lasting Vγ2Vδ2 T cell immunity by mimicking a natural infection. Therefore, we metabolically engineered the avirulent aroA(-) Salmonella enterica serovar Typhimurium SL7207 strain by deleting the gene for LytB (the downstream enzyme from HMBPP) and functionally complementing for this loss with genes encoding mevalonate pathway enzymes. LytB(-) Salmonella SL7207 had high HMBPP levels, infected human cells as efficiently as did the wild-type bacteria, and stimulated large ex vivo expansions of Vγ2Vδ2 T cells from human donors. Importantly, vaccination of a rhesus monkey with live lytB(-) Salmonella SL7207 stimulated a prolonged expansion of Vγ2Vδ2 T cells without significant side effects or anergy induction. These studies provide proof-of-principle that metabolic engineering can be used to derive live bacterial vaccines that boost Vγ2Vδ2 T cell immunity. Similar engineering of metabolic pathways to produce lipid Ags or B vitamin metabolite Ags could be used to derive live bacterial vaccine for other unconventional T cells that recognize nonpeptide Ags.
AuthorsGrefachew Workalemahu, Hong Wang, Kia-Joo Puan, Mohanad H Nada, Tomohisa Kuzuyama, Bradley D Jones, Chenggang Jin, Craig T Morita
JournalJournal of immunology (Baltimore, Md. : 1950) (J Immunol) Vol. 193 Issue 2 Pg. 708-21 (Jul 15 2014) ISSN: 1550-6606 [Electronic] United States
PMID24943221 (Publication Type: Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't, Research Support, U.S. Gov't, Non-P.H.S.)
Chemical References
  • 4-hydroxy-3-methyl-2-butenyl diphosphate
  • Bacterial Proteins
  • Organophosphates
  • Receptors, Antigen, T-Cell, gamma-delta
  • Salmonella Vaccines
  • Mevalonic Acid
Topics
  • Animals
  • Bacterial Proteins (genetics, immunology, metabolism)
  • Cell Proliferation
  • Cells, Cultured
  • Gene Deletion
  • Humans
  • Immunization
  • Lymphocyte Activation (immunology)
  • Macaca mulatta (immunology)
  • Metabolic Engineering (methods)
  • Metabolic Networks and Pathways (genetics, immunology)
  • Mevalonic Acid (metabolism)
  • Organophosphates (metabolism)
  • Receptors, Antigen, T-Cell, gamma-delta (immunology, metabolism)
  • Salmonella Vaccines (immunology)
  • Salmonella typhimurium (genetics, immunology, metabolism)
  • T-Lymphocytes (immunology, metabolism)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: